| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633751A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors |
| 03/15/2006 | EP1633749A2 Deazaflavin compounds and methods of use thereof |
| 03/15/2006 | EP1633738A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors |
| 03/15/2006 | EP1633735A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 03/15/2006 | EP1633718A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s |
| 03/15/2006 | EP1633713A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3 |
| 03/15/2006 | EP1633712A2 Six membered amino-amide derivatives as angiogenesis inhibitors |
| 03/15/2006 | EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors |
| 03/15/2006 | EP1633396A1 Cd20 binding molecules |
| 03/15/2006 | EP1633394A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 03/15/2006 | EP1633380A2 Antimicrobial and anticancer lipopeptides |
| 03/15/2006 | EP1633365A1 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 03/15/2006 | EP1633352A1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain |
| 03/15/2006 | EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 03/15/2006 | EP1633342A2 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 03/15/2006 | EP1633341A2 Methods for the selective treatment of tumors by calcium-mediated induction of apoptosis |
| 03/15/2006 | EP1633316A2 Antibodies that immunospecifically bind to trail receptors |
| 03/15/2006 | EP1633309A2 Method of inhibiting tumor growth with anti-tissue factor antibodies |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1470155B1 Pluripotency determining factor and uses thereof |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1435908A4 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 03/15/2006 | EP1417300B1 Process for the maturation of dentritic cells and a vaccine |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1372648B1 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 03/15/2006 | EP1331937B1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | EP1227085B1 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 03/15/2006 | EP1044022B1 Compositions and methods for targeted delivery of factors |
| 03/15/2006 | EP0934292B1 Metalloproteinase inhibitors |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | EP0784477B1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 03/15/2006 | CN1748029A Oligomeric compounds for the modulation of survivin expression |
| 03/15/2006 | CN1747984A Polymer guanidine derivatives as a cytostatic medicament |
| 03/15/2006 | CN1747964A Medicament for inhibiting tumour growth |
| 03/15/2006 | CN1747953A Aryl / hetaryl substituted imidazoquinolines. |
| 03/15/2006 | CN1747952A Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 03/15/2006 | CN1747950A 2-(1h-indazole-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 03/15/2006 | CN1747948A Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents |
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746184A Trichosanthin mutant and coding gene thereof |
| 03/15/2006 | CN1746164A Protein antagonist with water channel |
| 03/15/2006 | CN1745845A Chinese medicinal composition for treating and inhibiting tumor, its preparation and use |
| 03/15/2006 | CN1745843A Anticancer Chinese medicine compound preparation and its making method thereof |
| 03/15/2006 | CN1745782A Taxol fruit infusion granule |
| 03/15/2006 | CN1745759A External-applied medicine for inhibitting and killing cancer and tumor cells |
| 03/15/2006 | CN1745758A Compound taxol Chinese medicinal preparation |
| 03/15/2006 | CN1745749A Likejun capsule and production thereof |
| 03/15/2006 | CN1245407C Composition of garcinolic acid compounds, its preparing process and medical composition using it as active component |
| 03/15/2006 | CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof |
| 03/15/2006 | CN1245388C Process for synthesis of lonidamine |
| 03/15/2006 | CN1245385C Indole and dihydroindole derivatives |
| 03/15/2006 | CN1245382C 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245215C Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor |
| 03/15/2006 | CN1245213C Microcapsule meterial for durative releasing two factors for restraining new-born blood vessels and its preparing method |
| 03/15/2006 | CN1245207C Modified technique for making zedoary turmeric oil and glucose injection |
| 03/15/2006 | CN1245205C Chinese medicine for treating alimentary system malignant tumour |
| 03/15/2006 | CN1245167C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 03/15/2006 | CA2480231A1 Rapid insufflation drug compartment |
| 03/14/2006 | US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012095 Compounds for modulating cell proliferation |
| 03/14/2006 | US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012079 (5R)-5-ethyl-9,10,difluoro-5-hydroxy-12-(2-trimethylsilylethyl)-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]-indoloizino[1,2-b]quinoline-3,15-dione for treatment of colon cancer |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | US7012076 Quinazoline-4-sulfonamide derivatives |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012068 Reduced toxicity; enhance efficiency; side effect reduction |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011851 Drug delivery; incontinence therapy |
| 03/14/2006 | US7011845 For therapy and prophylaxis of infection or tumor |
| 03/14/2006 | CA2584412A1 Methods for diagnosis and treatment of cancer |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2268796C Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2250731C In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2147984C Butenyl-substituted taxanes and composition |
| 03/09/2006 | WO2006026656A1 Cytotoxic nucleoside analog compound 003 for treating cancer |
| 03/09/2006 | WO2006026500A1 New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders |
| 03/09/2006 | WO2006026348A1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 03/09/2006 | WO2006025567A1 Novel substituted imidazole derivatives |
| 03/09/2006 | WO2006025490A1 Molecular chaperone function regulator |
| 03/09/2006 | WO2006025431A1 Antagonist against tolerance to anticancer drugs |
| 03/09/2006 | WO2006025411A1 Liposome improving intracellular drug delivery |
| 03/09/2006 | WO2006025286A1 Constitutional function-improving agents |
| 03/09/2006 | WO2006025251A1 Physiologically active substances biselide a, biselide b, and biselide c, processes for producing these, and uses of these |
| 03/09/2006 | WO2006024863A1 Stable crystal form of imatinib mesylate and process for the preparation thereof |